drugset / Trial / NCT00315367

A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties

NCT00315367

Phase 4 Completed 26 enrolled Neurognostics
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine if medication designed to improve memory will help patients with Multiple Sclerosis (MS) who are experiencing memory problems using fMRI to track brain activity.

Timeline

Start
2004-09
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule